PixCell Medical
Dr. David Stein is the Board Chairman of PixCell Medical. David is currently focused on advising and investing in Start-up and growth companies as a founder, advisor, and Board Member. David is also currently a Director at Babson Diagnostics in Austin Texas. Until December 31, 2019, David was the Global Head of Strategy and the President of Molecular Diagnostics for Siemens Healthineers and was a key lead in the IPO of the company. Prior to this, David was the CEO of the Siemens Healthineers Point of Care Business and the Head of Strategy for the Diagnostics Division. David joined Siemens in 2001 and, through positions of increasing responsibility in product development, business operations, and portfolio strategy, has directed development and strategy for a number of successful products in the DX portfolio. Dr. Stein holds a Ph.D. in Engineering from The Johns Hopkins University, Baltimore, USA.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
PixCell Medical
3 followers
PixCell Medical provides the first truly portable point-of-care blood diagnostic solution. Leveraging the company’s patented Viscoelastic Focusing technology, along with AI-powered machine vision, PixCell’s FDA-cleared and CE-cleared HemoScreen diagnostic platform shortens diagnostic results delivery from days to minutes. With just one drop of blood and within five minutes, PixCell delivers accurate readings of 20 standard blood count parameters, saving patients, clinicians and health systems significant time and costs.